Willkie

Freedom House Welcomes New Board Co-Chair Wendell L. Willkie, II

Retrieved on: 
Thursday, October 19, 2023
Fascism, United States Secretary of Education, Democracy, Freedom, GOP, II, Government, Wendell, Congress, Commerce, U.S. Department of Commerce Office of Security, Research, Nazi Germany, Multimedia, Freedom House, Private sector, Ronald Reagan, Willkie, Democrat, U.S. Department of Defense Strategy for Operating in Cyberspace, American Enterprise Institute, Airline, Management, Trustee, New York University

WASHINGTON, Oct. 19, 2023 /PRNewswire/ -- Freedom House is pleased to announce that Wendell L. Willkie, II will join former Congresswoman Jane Harman as co-chair of the Freedom House Board of Trustees.

Key Points: 
  • WASHINGTON, Oct. 19, 2023 /PRNewswire/ -- Freedom House is pleased to announce that Wendell L. Willkie, II will join former Congresswoman Jane Harman as co-chair of the Freedom House Board of Trustees.
  • "Wendell's exceptional experience in senior posts in government, the private sector, and academia make him a perfect partner to lead Freedom House during these tumultuous times.
  • "I could not be more pleased that Wendell is rejoining the board in such an important leadership position," said Michael J. Abramowitz, president of Freedom House.
  • He served on the Freedom House Board between 1993 and 2005, and more recently as an emeritus trustee.

EQS-News: Willkie Farr & Gallagher LLP: Willkie advised Ardian on the acquisition financing of LIFTKET Group

Retrieved on: 
Thursday, May 11, 2023
LLP, Private law, Tax, Sale, Willkie, Farr, Acquisition, Corporation, Willkie Farr & Gallagher, News, Financial services, Security (finance), Cryptocurrency, Finance, Ardian

Willkie Farr & Gallagher LLP: Willkie advised Ardian on the acquisition financing of LIFTKET Group

Key Points: 
  • Willkie Farr & Gallagher LLP: Willkie advised Ardian on the acquisition financing of LIFTKET Group
    The issuer is solely responsible for the content of this announcement.
  • Willkie advised Ardian France S.A. ("Ardian") on the acquisition financing of a majority stake in LIFTKET Group ("LIFTKET").
  • Founded in 1948 in Wurzen, Germany, LIFTKET is a leading European manufacturer of electric chain hoists and control systems for sensitive uses.
  • Willkie Farr & Gallagher LLP provides leading-edge legal solutions on complex, business critical issues spanning markets and industries.

Raines Feldman Continues to Attract Top New York Talent as Leaders of Elite Corporate and Bankruptcy Boutiques Reunite

Retrieved on: 
Tuesday, September 20, 2022
Consulting, Professional Services, Legal, Cadwalader, AM, Culture, Mitchell Cohen, Trust, Willkie Farr & Gallagher, Reed Smith, Bankruptcy, Growth, Philosophy, Media Five Entertainment, Goal, Venable LLP, Multimedia, Lawyer, Financial services, Sandro Callari, Willkie

Raines Feldman continues its rapid expansion in New York with the recent addition of three additional partners and boutique firm leaders to its newly opened Midtown office, further strengthening the firms bankruptcy and corporate practice groups.

Key Points: 
  • Raines Feldman continues its rapid expansion in New York with the recent addition of three additional partners and boutique firm leaders to its newly opened Midtown office, further strengthening the firms bankruptcy and corporate practice groups.
  • In 2014, she founded Callari Partners LLP which ultimately grew to seven attorneys, including former Cadwalader attorney David Forsh who has also joined Raines Feldman as a partner.
  • Gregg Shulklapper, a former Willkie alum and colleague of Callari, has also joined Raines Feldman as a partner in the firms corporate practice group.
  • Other recent additions include former Reed Smith corporate partner Mitchell Cohen in Los Angeles, and former Troutman Pepper corporate partner Derek Dundas in Orange County.

DGAP-News: Willkie Farr & Gallagher LLP: Willkie advises Greystar on the Acquisition of Project Development HAR 6 in Hamburg-Harburg

Retrieved on: 
Friday, April 1, 2022
Real estate, Project, Hamburg-Harburg station, Willkie, Partner, Farr, News, DGAP, Associate, Willkie Farr & Gallagher, Seventh Avenue, Counsel, Harburger, Company, International law, Security (finance), Property management, Greystar Real Estate Partners

Willkie Farr & Gallagher LLP: Willkie advises Greystar on the Acquisition of Project Development HAR 6 in Hamburg-Harburg

Key Points: 
  • Willkie Farr & Gallagher LLP: Willkie advises Greystar on the Acquisition of Project Development HAR 6 in Hamburg-Harburg
    The issuer is solely responsible for the content of this announcement.
  • Greystar has acquired the residential project development "HAR6" in Hamburg Harburg from BPD Immobilienentwicklung.
  • The forward deal is part of Greystar's develop-to-core venture with a global institutional investor to build a diversified, high-quality rental apartment portfolio in Germany and Austria.
  • Tax advice was provided by Dr. Bettina Bokeloh (Partner, Tax, Frankfurt) and Dr. Wulf Kring (Counsel, Tax, Frankfurt).

Precision BioSciences Appoints Sam Wadsworth, Ph.D. and Shari Lisa Piré, J.D. to Board of Directors

Retrieved on: 
Monday, November 8, 2021
Health, Medical Devices, Technology, Genetics, Pharmaceutical, Hardware, Biotechnology, Slate, Industry, Therapy, Clinical trial, Willkie, Wi-Fi, Insurance, Machine learning, Precision, Growth, COVID-19, List, Acquisition, Chicago (franchise), Board of directors, Genzyme, Charles River Laboratories, New York Law School, Safety, Privacy, III, CDMO, Leadership, Ownership, Technology, Research, Forward-looking statement, Sustainability, Biotechnology, Gene editing, Patient, AAV, CAR, Compliance, Achievement, Private Securities Litigation Reform Act, Investor, Infection, Cognate, Willkie Farr & Gallagher, Multimedia, AI, Sale, SEC, Drug discovery, Sam, University, Plume, Ultragenyx, Board, Investigational New Drug, Genome, Nasdaq, IND, Intellectual property, Pharmaceutical industry

View the full release here: https://www.businesswire.com/news/home/20211108005415/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211108005415/en/
    Sam Wadsworth, Ph.D., Chief Scientific Officer of Ultragenyx Gene Therapy, an operating unit of Ultragenyx Pharmaceutical Inc., has been appointed to Precision BioSciences' Board of Directors.
  • With the appointments of Sam and Shari, in addition to Michael Amoroso and Stan Frankel, M.D.
  • who recently joined the Precision BioSciences Board, we are building an exceptional Board with diverse business experience.
  • Dr. Wadsworth has nearly 30 years of industry experience at Genzyme (later Sanofi Genzyme), followed by Ultragenyx Therapeutics.

DGAP-News: Willkie Farr & Gallagher LLP: Willkie advises Deutsche Bank AG on the financing of the investment in Simon Hegele Group by EMZ Partners

Retrieved on: 
Tuesday, September 14, 2021
Seventh Avenue, EMZ, Farr, LLP, International law, Group, Wilms, MBO, News, Willkie, Growth, Deutsche Bank, Willkie Farr & Gallagher, Company, DGAP, Financial services, Security (finance), Airline

Willkie Farr & Gallagher LLP: Willkie advises Deutsche Bank AG on the financing of the investment in Simon Hegele Group by EMZ Partners

Key Points: 
  • Willkie Farr & Gallagher LLP: Willkie advises Deutsche Bank AG on the financing of the investment in Simon Hegele Group by EMZ Partners
    The issuer is solely responsible for the content of this announcement.
  • Willkie Farr & Gallagher LLP ("Willkie") advised Deutsche Bank AG in its capacity as Documentation Agent, Mandated Lead Arranger and Lender on the financing of the investment in Simon Hegele Group by EMZ Partners.
  • The credit facilities advanced by Deutsche Bank AG and other lenders provide for a substantial component of the capital structure for EMZ Partners' investment and supports future growth of the Simon Hegele Group.
  • The investment by EMZ Partners is structured as a management buyout (MBO) as part of an orderly succession plan.

DGAP-News: Willkie Farr & Gallagher LLP: Willkie advises 3i Group plc on the investment in MAIT GmbH

Retrieved on: 
Wednesday, August 4, 2021
3i, Willkie, 3I, Mait, Service companies

Willkie Farr & Gallagher LLP: Willkie advises 3i Group plc on the investment in MAIT GmbH

Key Points: 
  • Willkie Farr & Gallagher LLP: Willkie advises 3i Group plc on the investment in MAIT GmbH
    The issuer is solely responsible for the content of this announcement.
  • Willkie Farr & Gallagher LLP advised 3i Group plc ("3i") on their investment in MAIT GmbH ("MAIT"), a leading provider of innovative and pioneering digital solutions in the DACH region.
  • MAIT Group, headquartered in Rottweil, Germany, provides innovative and pioneering digital solutions in product lifecycle management ("PLM"), enterprise resource planning ("ERP") and IT services generating approx.
  • 3i is an investment company with two complementary businesses, Private Equity and Infrastructure, specializing in core investment markets in Northern Europe and North America.

Omnicell to Acquire FDS Amplicare

Retrieved on: 
Monday, July 26, 2021
Software, Practice Management, Pharmaceutical, Managed care, Health, Data management, Hospitals, Technology, Law firms, Omnicell, Willkie Farr & Gallagher, Sidley, Evercore, Willkie, FDS Amplicare, Omnicell, FDS AMPLICARE, OMNICELL

"The COVID-19 pandemic has accelerated the transformation to the New Era Pharmacy, said Adam McMullin, chief executive officer, FDS Amplicare.

Key Points: 
  • "The COVID-19 pandemic has accelerated the transformation to the New Era Pharmacy, said Adam McMullin, chief executive officer, FDS Amplicare.
  • Evercore served as financial advisor and provided a fairness opinion to Omnicell and Sidley Austin LLP served as legal counsel to Omnicell.
  • Baird served as financial advisor to FDS Amplicare, and Willkie Farr & Gallagher served as legal counsel to FDS Amplicare.
  • OMNICELL, the Omnicell logo and EnlivenHealth are registered trademarks or trademarks of Omnicell, Inc. or one of its subsidiaries.

DGAP-News: Willkie Farr & Gallagher LLP: Willkie advises Bregal Milestone on its Series C investment in Uberall

Retrieved on: 
Thursday, June 17, 2021
Willkie, Investment, Limited liability partnership, Articles, Companies

Willkie Farr & Gallagher LLP: Willkie advises Bregal Milestone on its Series C investment in Uberall

Key Points: 
  • Willkie Farr & Gallagher LLP: Willkie advises Bregal Milestone on its Series C investment in Uberall
    The issuer is solely responsible for the content of this announcement.
  • Willkie Farr & Gallagher LLP advised Bregal Milestone as lead investor in the USD 115 million Series C growth investment in Uberall.
  • Existing investors of Uberall are HPE Growth and Project A.
  • The transaction is Bregal Milestone's tenth investment and first transaction in Germany.

DGAP-News: Willkie Farr & Gallagher LLP: MorphoSys to acquire Constellation Pharmaceuticals

Retrieved on: 
Tuesday, June 8, 2021
MorphoSys, Willkie

Willkie Farr & Gallagher LLP: MorphoSys to acquire Constellation Pharmaceuticals

Key Points: 
  • Willkie Farr & Gallagher LLP: MorphoSys to acquire Constellation Pharmaceuticals
    The issuer is solely responsible for the content of this announcement.
  • Willkie represents Constellation Pharma-ceuticals in connection with MorphoSys's acquisition of Constellation Pharm-aceuticals.
  • On June 2, 2021, MorphoSyS and Constellation Pharmaceuticals announced that they have entered into a definitive agreement whereby MorphoSys will acquire Con-stellation Pharmaceuticals for USD 34.00 per share in cash, which represents a total equity value of approx.
  • The transaction has been unanimously approved by the management board and the supervisory board of MorphoSys as well as the board of directors of Constellation Pharmaceuticals.